Quantcast

Latest Teva Pharmaceutical Industries Stories

2011-06-17 08:31:00

CHICAGO, June 17, 2011 /PRNewswire/ -- Seven Summits Research issues critical PriceWatch Alerts for GE, AMD, TEVA, WHR, and TIBX. To see what our analysts have discovered about these stocks read the Seven Summits Strategic Investments' PriceWatch Alerts at http://www.iotogo.com/s/061711A (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's PriceWatch Alerts cover the following stocks: General Electric Co. (NYSE: GE), Advanced Micro Devices, Inc....

2011-06-15 08:13:00

ALLEGAN, Mich., June 15, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that its partner Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) (previously Barr Laboratories Inc.) has begun shipping Triamcinolone Acetonide Nasal Spray. Perrigo's partner Teva was the first applicant to file a complete ANDA with a Paragraph IV certification for Nasacort AQ and will be launching the product with 180 days of generic exclusivity. The Hatch Waxman litigation between Teva...

2011-05-27 08:30:00

CHICAGO, May 27, 2011 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Mylan Inc. (NYSE: MYL), Abbott Laboratories (NYSE: ABT), Ista Pharmaceuticals Inc (Nasdaq: ISTA), Johnson & Johnson (NYSE: JNJ) and Teva Pharmaceuticals (Nasdaq: TEVA). (Logo:...

2011-05-17 07:00:00

BOTHELL, WA, and VANCOUVER, May 17 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that Cameron Lawrence, OncoGenex' Director of Finance and Principal Accounting Officer, will be presenting at the UBS Global Specialty Pharmaceuticals Conference on Wednesday, May 25 at 10:00 a.m. BST (5:00 a.m. ET). The conference takes place at the UBS offices in London. The live audio webcast can be accessed through the Investor Relations page of the OncoGenex website...

2011-05-16 11:05:00

PHILADELPHIA, May 16, 2011 /PRNewswire/ -- The Phillies and Teva Respiratory are teaming up to raise awareness of asthma, which continues to be a widespread issue in the city of Philadelphia. For the second year in a row, Teva Respiratory is hosting Phillies Asthma Awareness Night in partnership with the American College of Allergy, Asthma and Immunology (ACAAI) on Thursday, May 19 at Citizens Bank Park, before and during the 7:05 p.m. Phillies game against the Colorado Rockies. As part...

2011-05-16 07:00:00

REDWOOD CITY, Calif., May 16, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced the continued expansion of its collaboration with Teva Pharmaceutical Industries Ltd., the world's largest generic drug manufacturer. Codexis has now successfully completed technology transfer of custom biocatalysts for manufacture of three undisclosed pharmaceutical products to Teva. Two products have been transferred to pilot manufacturing and a third to full scale commercial manufacturing....

2011-05-02 10:22:00

MISSISSAUGA, Ontario, May 2, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today congratulated Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Cephalon, Inc. (NASADQ: CEPH) on their announcement that Cephalon has agreed to be acquired by Teva. In response to the news, Valeant has withdrawn its consent solicitation. "We believe that this announcement is positive news for Cephalon stockholders and we are pleased that Teva has paid what we...

2011-05-02 07:00:00

BOTHELL, WA and VANCOUVER, May 2 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced that the Company's first quarter 2011 financial results will be released on Monday, May 9, 2011 after the NASDAQ Global Market closes at 4:00 p.m. ET, and that the Company will host a conference call and live webcast at 4:30 p.m. ET that afternoon. Management will discuss the company's financial results and provide an update on the business. To access the webcast, log...

2011-04-13 13:17:00

ALLEGAN, Mich., April 13, 2011 /PRNewswire/ -- Perrigo (Nasdaq: PRGO;TASE) today announced that its partner, Teva Pharmaceutical Industries, Ltd. (Nasdaq: TEVA), has received final OTC approval to sell and distribute fexofenadine HCl 60 mg and 180 mg tablets; the generic equivalents of Sanofi-Aventis' Allegra 60 mg and 180 mg products. Teva has had Rx approval for these products, and Teva and Sanofi-Aventis have settled their Paragraph IV/Hatch-Waxman litigation relating to the Allegra...

2011-03-29 07:00:00

BOTHELL, WA and VANCOUVER, BC, March 29 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that Scott Cormack, OncoGenex' president and chief executive officer, will provide a corporate presentation at the Needham & Company 10(th) Annual Healthcare Conference on Wednesday, April 6 at 2:40 p.m. ET. The corporate presentation will be webcast live and can be accessed through the Investor Relations page of the OncoGenex website at...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'